Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Liver cancer Clinical Trials

Protocol Number Title
2011IS114
A Randomized, Double-Blind, Multi-Center Phase III Study of ADI‑PEG 20 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed Prior Systemic Therapy
2011IS155
A RANDOMIZED, PLACEBO-CONTROLLED, MULTI-SITE PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF PREEMPTIVE TREATMENT WITH CMX001 FOR THE PREVENTION OF ADENOVIRUS DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION (THE ADV HALT TRIAL)
2011OC057
MT2011-09C Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients with High Risk or Relapsed Solid Tumor
2012IS127
A randomized, double blind, placebo-controlled, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib
2013IS025
A Phase 3, randomized, double-blind study with Tivantinib (ARQ 197) in subjects with met diagnostic-high inoperable hepatocellular carcinoma (HCC) treated with one prior systemic therapy
2013IS044
An open-label, parallel-group, multicenter phase I study to investigate the pharmacokinetics of NKTR-102 for injection (Etirinotecan pegol) in patients with advanced or metastatic solid tumors and mild or moderate hepatic impairment (Nektar 12-102-13)

6 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on